SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Bhiladvala P)
 

Sökning: WFRF:(Bhiladvala P) > Bivalirudin versus ...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00012607naa a2200997 4500
001oai:DiVA.org:oru-61701
003SwePub
008171113s2017 | |||||||||||000 ||eng|
009oai:DiVA.org:umu-140649
009oai:DiVA.org:uu-336480
009oai:prod.swepub.kib.ki.se:136678815
009oai:lup.lub.lu.se:e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb8
009oai:DiVA.org:liu-141843
024a https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-617012 URI
024a https://doi.org/10.1056/NEJMoa17064432 DOI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1406492 URI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-3364802 URI
024a http://kipublications.ki.se/Default.aspx?queryparsed=id:1366788152 URI
024a https://lup.lub.lu.se/record/e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb82 URI
024a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1418432 URI
040 a (SwePub)orud (SwePub)umud (SwePub)uud (SwePub)kid (SwePub)lud (SwePub)liu
041 a engb eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Erlinge, D.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)kard-der
2451 0a Bivalirudin versus Heparin Monotherapy in Myocardial Infarction
264 1b Massachusetts Medical Society,c 2017
338 a print2 rdacarrier
500 a Funding agencies:AstraZeneca and the Medicines Company
500 a Funding Agencies|Swedish Heart-Lung Foundation; Swedish Research Council; AstraZeneca; Medicines Company; Swedish Foundation for Strategic Research (as part of the TOTAL-AMI project)
520 a Background The comparative efficacy of various anticoagulation strategies has not been clearly established in patients with acute myocardial infarction who are undergoing percutaneous coronary intervention (PCI) according to current practice, which includes the use of radial-artery access for PCI and administration of potent P2Y12 inhibitors without the planned use of glycoprotein IIb/IIIa inhibitors. Methods In this multicenter, randomized, registry-based, open-label clinical trial, we enrolled patients with either ST-segment elevation myocardial infarction (STEMI) or non-STEMI (NSTEMI) who were undergoing PCI and receiving treatment with a potent P2Y12 inhibitor (ticagrelor, prasugrel, or cangrelor) without the planned use of glycoprotein IIb/IIIa inhibitors. The patients were randomly assigned to receive bivalirudin or heparin during PCI, which was performed predominantly with the use of radial-artery access. The primary end point was a composite of death from any cause, myocardial infarction, or major bleeding during 180 days of follow-up. Results A total of 6006 patients (3005 with STEMI and 3001 with NSTEMI) were enrolled in the trial. At 180 days, a primary end-point event had occurred in 12.3% of the patients (369 of 3004) in the bivalirudin group and in 12.8% (383 of 3002) in the heparin group (hazard ratio, 0.96; 95% confidence interval [CI], 0.83 to 1.10; P=0.54). The results were consistent between patients with STEMI and those with NSTEMI and across other major subgroups. Myocardial infarction occurred in 2.0% of the patients in the bivalirudin group and in 2.4% in the heparin group (hazard ratio, 0.84; 95% CI, 0.60 to 1.19; P=0.33), major bleeding in 8.6% and 8.6%, respectively (hazard ratio, 1.00; 95% CI, 0.84 to 1.19; P=0.98), definite stent thrombosis in 0.4% and 0.7%, respectively (hazard ratio, 0.54; 95% CI, 0.27 to 1.10; P=0.09), and death in 2.9% and 2.8%, respectively (hazard ratio, 1.05; 95% CI, 0.78 to 1.41; P=0.76). Conclusions Among patients undergoing PCI for myocardial infarction, the rate of the composite of death from any cause, myocardial infarction, or major bleeding was not lower among those who received bivalirudin than among those who received heparin monotherapy. (Funded by the Swedish Heart-Lung Foundation and others; VALIDATE-SWEDEHEART ClinicalTrialsRegister.eu number, 2012-005260-10 ; ClinicalTrials.gov number, NCT02311231 .).
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
700a Omerovic, Elmiru Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut
700a Fröbert, Ole,d 1964-u Örebro University,Örebro universitet,Institutionen för medicinska vetenskaper,Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden,Rebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden.4 aut0 (Swepub:oru)oft
700a Linder, Rikardu Karolinska Institutet,Danderyd Hospital, Sweden4 aut
700a Danielewicz, Mikaelu PCI-Unit at Karlstad Hospital, Karlstad, Sweden,Karlstad Hosp, PCI Unit, Karlstad, Sweden.4 aut
700a Hamid, Mehmetu Department of Cardiology, Mälarsjukhuset, Eskilstuna, Sweden,Malarsjukhuset, Dept Cardiol, Eskilstuna, Sweden.4 aut
700a Swahn, Evau Linköpings universitet,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Kardiologiska kliniken US4 aut0 (Swepub:liu)evasw45
700a Henareh, Loghmanu Karolinska Institutet,Karolinska University Hospital, Sweden4 aut
700a Wagner, H.u Department of Cardiology, Helsingborg Lasarett, Helsingborg, Sweden,Helsingborg Lasarett, Dept Cardiol, Helsingborg, Sweden.,Helsingborg Hospital4 aut0 (Swepub:lu)med-hkw
700a Hårdhammar, Peteru Department of Cardiology, Halmstad Hospital, Halmstad, Sweden,Halmstad Cty Hosp, Dept Cardiol, Halmstad, Sweden.,Halmstad County Hospital, Sweden4 aut
700a Sjögren, Iwaru Department of Cardiology, Falun Hospital, Falun, Sweden,Falun Cent Hosp, Dept Cardiol, Falun, Sweden.,Falun Central Hospital, Sweden4 aut
700a Stewart, Jasonu Department of Cardiology, Skaraborgs Hospital, Skövde, Sweden,Skaraborgs Hosp, Dept Cardiol, Skovde, Sweden.4 aut
700a Grimfjärd, Peru Department of Internal Medicine, Västmanlands Sjukhus, Västerås, Sweden,Vastmanlands Sjukhus, Dept Internal Med, Vasteras, Sweden.,Västmanland Hospital4 aut
700a Jensen, Jensu Umeå University,Karolinska Institute,Karolinska Institutet,Karolinska Institute, Sweden,Sunderby Sjukhus, Sweden,Umeå University, Sweden4 aut
700a Aasa, Mikaelu Department of Cardiology, Södersjukhuset AB, Stockholm, Sweden,Sodersjukhuset AB, Dept Cardiol, Stockholm, Sweden.,Stockholm South General Hospital4 aut
700a Robertsson, Lottau Department of Internal Medicine, Västmanlands Sjukhus, Västerås, Sweden,Sodra Alvsborgs Sjukhus, Dept Cardiol, Boras, Sweden.,South Elfsborg Hospital4 aut
700a Lindroos, Pontusu Department of Cardiology, Capio St. Görans Hospital, Karolinska Institutet, Stockholm, Sweden,Karolinska Inst, Capio St Gorans Hosp, Dept Cardiol, Stockholm, Sweden.,Capio St. Görans Sjukhus4 aut
700a Haupt, Janu Department of Cardiology, Sunderby Sjukhus, Luleå, Sweden,Sunderby Hospital4 aut
700a Wikström, Helenau Department of Cardiology, Kristianstad Hospital, Kristianstad, Sweden,Kristianstad Hosp, Dept Cardiol, Kristianstad, Sweden.,Central Hospital Kristianstad4 aut
700a Ulvenstam, Andersu Umeå universitet,Avdelningen för medicin,Ostersund Hosp, Dept Cardiol, Ostersund, Sweden.,Östersund Hospital, Sweden4 aut0 (Swepub:umu)anul0039
700a Bhiladvala, P.u Lund University,Lunds universitet,Kardiologiska klinikens forskargrupp,Forskargrupper vid Lunds universitet,Cardiology Research Group,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)medf-pbh
700a Lindvall, Bou Department of Cardiology, Sundsvall Hospital, Sundsvall, Sweden,Sundsvall Hosp, Dept Cardiol, Sundsvall, Sweden.4 aut
700a Lundin, Andersu Department of Cardiology, Clinical Sciences, Lund University, Lund, Sweden,Lund Univ, Dept Cardiol Clin Sci, Lund, Sweden.4 aut
700a Tödt, T.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden,Sahlgrens University Hospital, Sweden,Örebro University, Sweden4 aut0 (Swepub:lu)med-ttt
700a Ioanes, Danu Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut
700a Råmunddal, Trulsu Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden4 aut
700a Kellerth, Thomasu Örebro University4 aut
700a Zagozdzon, Leszeku Örebro University,Örebro University, Sweden4 aut
700a Götberg, M.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden4 aut0 (Swepub:lu)kard-mgo
700a Andersson, Jonasu Umeå universitet,Kardiologi4 aut0 (Swepub:umu)joan0102
700a Angerås, Oskaru Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden,Sahlgrens Univ Hosp, Dept Cardiol, Gothenburg, Sweden.4 aut
700a Östlund, Ollieu Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Uppsala University, Sweden4 aut0 (Swepub:uu)oos27600
700a Lagerqvist, Bo,d 1952-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)bolager
700a Held, Claes,d 1956-u Uppsala universitet,Uppsala kliniska forskningscentrum (UCR),Kardiologi,Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)clahe947
700a Wallentin, Lars,d 1943-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)larswall
700a Scherstén, F.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Lund University, Sweden4 aut0 (Swepub:lu)med-fds
700a Eriksson, Peteru Umeå University,Umeå universitet,Kardiologi,Umea Univ, Dept Cardiol, Umea, Sweden.,Umeå University, Sweden4 aut0 (Swepub:umu)ernper00
700a Koul, S.u Lund University,Lunds universitet,Kardiologi,Sektion II,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Molekylär kardiologi,Forskargrupper vid Lunds universitet,Cardiology,Section II,Department of Clinical Sciences, Lund,Faculty of Medicine,Molecular Cardiology,Lund University Research Groups,Lund University, Sweden4 aut0 (Swepub:lu)med-sku
700a James, Stefan,d 1964-u Uppsala universitet,Kardiologi,Uppsala kliniska forskningscentrum (UCR),Uppsala University Hospital,Uppsala University, Sweden4 aut0 (Swepub:uu)stjam367
700a Linder, Robert,d 1981-u Umeå universitet,Lungmedicin4 aut0 (Swepub:umu)rotlir03
700a Abdel-Hamid, Mohamedu Mälar Hospital4 aut
700a Östlund, Olofu Uppsala University Hospital4 aut
710a Kardiologib Sektion II4 org
773t New England Journal of Medicined : Massachusetts Medical Societyg 377:12, s. 1132-1142q 377:12<1132-1142x 0028-4793x 1533-4406
856u http://dx.doi.org/10.1056/NEJMoa1706443y FULLTEXT
856u https://liu.diva-portal.org/smash/get/diva2:1147969/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-61701
8564 8u https://doi.org/10.1056/NEJMoa1706443
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-140649
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-336480
8564 8u http://kipublications.ki.se/Default.aspx?queryparsed=id:136678815
8564 8u https://lup.lub.lu.se/record/e4ba7cdd-12bf-4a3c-a9f5-319872ffbbb8
8564 8u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-141843

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy